By Marilyn T.  McGoldrick, Esq. Posted on Mar 4, 2015 The FDA has announced two important changes to the labeling of testosterone replacement (LowT) products. First, the makers of testosterone replacement medication must change the labels to make clear that “prescription testosterone products are approved only for men who have low testosterone levels caused by certain medical… Read More


Thornton Law Firm is no longer accepting new Xarelto cases. By Marilyn McGoldrick Posted on Dec 30, 2014 Patients taking the blood thinning medication Xarelto to prevent blood clots and strokes in patients with irregular heart rhythms have continued to experience uncontrollable bleeding and other serious side effects. Thornton Law Firm is currently filing claims on behalf… Read More


Posted by Marilyn McGoldrick on Sep 19, 2014 12:11:00 PM A panel of experts appointed to advise the FDA voted 20-1 this week to recommend the FDA warn consumers that testosterone treatments have not been shown to reverse common problems of aging like low libido, muscle loss or energy levels. Testosterone drug makers have been… Read More


Posted by Marilyn McGoldrick on Jun 12, 2014 11:51:51 AM You may have heard a radio or television advertisement targeting men concerning a condition known as “Low T” – shorthand for low testosterone.  The ads sell testosterone replacement therapies as a way of combating “Low T.”  The ads list “symptoms” of the condition that commonly… Read More


Men of all ages who are currently using or considering testosterone therapy for increased energy and libido should be aware of new research published in the Journal of the American Association of Medicine (JAMA). According to the study of 8000 men in the Veterans Administration health system, there may be a link between testosterone therapy and a greater risk of heart attacks, strokes, and even death.… Read More